文献
J-GLOBAL ID:201802278292469501
整理番号:18A1264060
再発または難治性急性骨髄性白血病患者における単独療法としてのFLT3阻害剤,キザチニブ:オープンラベル,多施設,単腕,第2相試験【JST・京大機械翻訳】
Quizartinib, an FLT3 inhibitor, as monotherapy in patients with relapsed or refractory acute myeloid leukaemia: an open-label, multicentre, single-arm, phase 2 trial
著者 (24件):
Cortes Jorge
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Perl Alexander E
(Division of Hematology and Oncology, Abramson Cancer Center of the University of Pennsylvania, Philadelphia, PA, USA)
,
Dohner Hartmut
(Department of Internal Medicine III, Ulm University Hospital, Ulm, Germany)
,
Kantarjian Hagop
(Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX, USA)
,
Martinelli Giovanni
(Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori (IRST) Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), Meldola, Italy)
,
Kovacsovics Tibor
(Center for Hematologic Malignancies, Oregon Health & Science University, Portland, OR, USA)
,
Rousselot Philippe
(Service d’Hematologie et Oncologie, Hopital de Versailles, Universite Versailles Saint-Quentin-en-Yvelines Paris-Saclay U1173, Le Chesnay, France)
,
Steffen Bjorn
(Department of Medicine II, Hematology/Oncology, Goethe University, Frankfurt, Germany)
,
Dombret Herve
(University Hospital Saint-Louis, Assistance Publique-Hopitaux de Paris (AP-HP), University Paris Diderot, Paris, France)
,
Estey Elihu
(Seattle Cancer Care Alliance, University of Washington School of Medicine, Seattle, WA, USA)
,
Strickland Stephen
(Vanderbilt-Ingram Cancer Center, Nashville, TN, USA)
,
Altman Jessica K
(Department of Medicine, Division of Hematology and Oncology, Robert H Lurie Comprehensive Cancer Center of Northwestern University, Chicago, IL, USA)
,
Baldus Claudia D
(Charite-Universitaetsmedizin Berlin, Campus Benjamin Franklin, Hematology and Oncology, Berlin, Germany)
,
Burnett Alan
(Department of Haematology, Cardiff University, Cardiff, Wales, UK)
,
Kraemer Alwin
(Klinische Kooperationseinheit Molekulare Haematologie/Onkologie, Medizinische Klinik V, Universitaet Heidelberg and German Cancer Research Center (DKFZ), Heidelberg, Germany)
,
Russell Nigel
(Department of Haematology, Nottingham University Hospital, Nottingham, UK)
,
Shah Neil P
(Department of Medicine, Division of Hematology and Oncology, University of California at San Francisco, San Francisco, CA, USA)
,
Smith Catherine C
(Department of Medicine, Division of Hematology and Oncology, University of California at San Francisco, San Francisco, CA, USA)
,
Wang Eunice S
(Department of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, NY, USA)
,
Ifrah Norbert
(Service des Maladies du Sang, Centre Hospitalier Universitaire d’Angers, Angers, France)
,
Gammon Guy
(Daiichi Sankyo, San Diego, CA, USA)
,
Trone Denise
(Daiichi Sankyo, San Diego, CA, USA)
,
Lazzaretto Deborah
(Daiichi Sankyo, San Diego, CA, USA)
,
Levis Mark
(The Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins University, Baltimore, MD, USA)
資料名:
Lancet Oncology
(Lancet Oncology)
巻:
19
号:
7
ページ:
889-903
発行年:
2018年
JST資料番号:
W1266A
ISSN:
1470-2045
資料種別:
逐次刊行物 (A)
記事区分:
原著論文
発行国:
オランダ (NLD)
言語:
英語 (EN)